Marcin Trojanowski MD
Assistant Professor, Rheumatology
72 East Concord Street | (617) 638-4312
Arthritis & Autoimmune Diseases Research Center
Marcin Trojanowski, MD Clinical Assistant Professor of Medicine Director, Rheumatology Clinic Director, Scleroderma Program Section of Rheumatology Boston University School of Medicine 72 East Concord Street, 5th floor Boston, MA 02118 Marcin Trojanowski, MD is a Clinical Assistant Professor of Medicine in Rheumatology at Boston University School of Medicine. He has a decade of experience in treatment of systemic sclerosis as well as a passion for medical teaching.
Prior to his arrival at BUMC, Dr. Trojanowski was the head of the Scleroderma Clinic at UAB where he was the primary referral in the region. In this role he carved out a regional role in both systemic sclerosis as well as CTD-ILD. At BUMC, he has overseen an ever expanding role within the scleroderma clinic. He also serves as the Clinical Director of the Division of Rheumatology. Dr. Trojanowski has worked on many translational and epidemiological research studies such as the Genome Research in African American Scleroderma Patients (GRASP). He has participated in directly sponsored pharmaceutical research as the principle and sub investigator of dozens of drug trials in systemic sclerosis, systemic lupus and more recently COVID 19.
In education, Dr. Trojanowski excelled at UAB as a top ten teacher in the Department of Medicine as well as a leading teacher in the Division of Rheumatology. He was a member of the Strategic Committee on Education at UAB Department of Medicine. At Boston University, Dr. Trojanowski is the director of the rheumatology musculoskeletal module for the second-year medical students and has developed a multidisciplinary problem-based learning module for first year students.
Chief Clinical Interests: Systemic Sclerosis, Connective Tissue Diseases, and Lung Disease in Connective Tissue Disease
MD, Medical University of South Carolina, 2006
Biology, BS, College of Charleston, 2001
Lui JK, Sangani RA, Chen CA, Bujor AM, Trojanowski MA, Gopal DM, LaValley MP, Wiener RS, Klings ES. The Prognostic Value of Cardiac Axis Deviation in Systemic Sclerosis-related Pulmonary Hypertension. Arthritis Care Res (Hoboken). 2021 Jun 03. PMID: 34085410.Published on 10/9/2020
Mazzotta C, Marden G, Farina A, Bujor A, Trojanowski MA, Trojanowska M. FLI1 and ERG protein degradation is regulated via Cathepsin B lysosomal pathway in human dermal microvascular endothelial cells. Microcirculation. 2021 01; 28(1):e12660. PMID: 32979864.Published on 7/31/2020
Marden G, Wan Q, Wilks J, Nevin K, Feeney M, Wisniacki N, Trojanowski M, Bujor A, Stawski L, Trojanowska M. The role of the oncostatin M/OSM receptor ß axis in activating dermal microvascular endothelial cells in systemic sclerosis. Arthritis Res Ther. 2020 07 31; 22(1):179. PMID: 32736577.Published on 12/23/2019
Gourh P, Safran SA, Alexander T, Boyden SE, Morgan ND, Shah AA, Mayes MD, Doumatey A, Bentley AR, Shriner D, Domsic RT, Medsger TA, Ramos PS, Silver RM, Steen VD, Varga J, Hsu V, Saketkoo LA, Schiopu E, Khanna D, Gordon JK, Kron B, Criswell LA, Gladue H, Derk CT, Bernstein EJ, Bridges SL, Shanmugam VK, Kolstad KD, Chung L, Kafaja S, Jan R, Trojanowski M, Goldberg A, Korman BD, Steinbach PJ, Chandrasekharappa SC, Mullikin JC, Adeyemo A, Rotimi C, Wigley FM, Kastner DL, Boin F, Remmers EF. HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry. Proc Natl Acad Sci U S A. 2020 01 07; 117(1):552-562. PMID: 31871193.Published on 8/29/2018
Gourh P, Remmers EF, Boyden SE, Alexander T, Morgan ND, Shah AA, Mayes MD, Doumatey A, Bentley AR, Shriner D, Domsic RT, Medsger TA, Steen VD, Ramos PS, Silver RM, Korman B, Varga J, Schiopu E, Khanna D, Hsu V, Gordon JK, Saketkoo LA, Gladue H, Kron B, Criswell LA, Derk CT, Bridges SL, Shanmugam VK, Kolstad KD, Chung L, Jan R, Bernstein EJ, Goldberg A, Trojanowski M, Kafaja S, Maksimowicz-McKinnon KM, Mullikin JC, Adeyemo A, Rotimi C, Boin F, Kastner DL, Wigley FM. Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans. Arthritis Rheumatol. 2018 10; 70(10):1654-1660. PMID: 29732714.Published on 12/1/2017
Morgan ND, Shah AA, Mayes MD, Domsic RT, Medsger TA, Steen VD, Varga J, Carns M, Ramos PS, Silver RM, Schiopu E, Khanna D, Hsu V, Gordon JK, Gladue H, Saketkoo LA, Criswell LA, Derk CT, Trojanowski MA, Shanmugam VK, Chung L, Valenzuela A, Jan R, Goldberg A, Remmers EF, Kastner DL, Wigley FM, Gourh P, Boin F. Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database. Medicine (Baltimore). 2017 Dec; 96(51):e8980. PMID: 29390428.